Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Spectracef (Cefditoren Pivoxil) Tablets, 200 mg, TAP Pharmaceutical Products NDA 21-222/S1 8/21/02 8/26/02 8/22/02 | Spectracef (Cefditoren Pivoxil) Tablets, 200 mg TAP Pharmaceutical Products NDA 21-222 8/29/01 11/5/01 11/5/01 12/7/01 | Spectracef Indications: Treatment of acute exacerbation of chronic bronchitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections. Spectracef (Cefditoren Pivoxil) Tablets, Purdue Pharmaceutical | Spectracef (cefditoren pivoxil) tablets, Purdue Pharma, Labeling Revision | SPECTRACEF (cefditoren pivoxil) Tablets, Cornerstone BioPharma, Formulation Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com